Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
Buntanetap tartrate by Annovis Bio for Parkinson's Disease: Likelihood of Approval
Buntanetap tartrate is under clinical development by Annovis Bio and currently in Phase III for Parkinson's Disease. According to GlobalData,...
Buntanetap tartrate by Annovis Bio for Alzheimer's Disease: Likelihood of Approval
Buntanetap tartrate is under clinical development by Annovis Bio and currently in Phase III for Alzheimer's Disease. According to GlobalData,...
Buntanetap tartrate by Annovis Bio for Frontotemporal Dementia (FTD): Likelihood of Approval
Buntanetap tartrate is under clinical development by Annovis Bio and currently in Phase I for Frontotemporal Dementia (FTD). According to...
Buntanetap tartrate by Annovis Bio for Alzheimer's Disease: Likelihood of Approval
Buntanetap tartrate is under clinical development by Annovis Bio and currently in Phase III for Alzheimer's Disease. According to GlobalData,...